Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04431479 · ClinicalTrials.gov registry record

Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study

A clinical trial of Chronic Graft Versus Host Disease, sponsored by Fred Hutchinson Cancer Center.

Recruiting
Registry status
300
Enrollment target
10
Study locations

NCT04431479 is a study of Chronic Graft Versus Host Disease that is actively recruiting participants, run by Fred Hutchinson Cancer Center. The registered enrollment target is 300 participants, above the 106-participant average among 30 other Chronic Graft Versus Host Disease trials with a reported enrollment target (183% higher). The trial reports 10 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04431479, a study of Chronic Graft Versus Host Disease, is actively recruiting participants, sponsored by Fred Hutchinson Cancer Center.

RECRUITING
Registry status
300 participants
Enrollment target
10
Study locations

Study Summary

This trial collects clinical data and blood samples to predict the quality of response to specific treatments in patients with chronic graft-versus-host disease (cGVHD) who are about to start a new therapy. Collecting and analyzing clinical data and blood samples from patients with cGVHD before and after treatment initiation may help doctors identify changes that may predict treatment response.

Conditions Studied

Chronic Graft Versus Host Disease

Interventions

  • PROCEDURE Biospecimen Collection
  • OTHER Quality-of-Life Assessment
  • OTHER Questionnaire Administration
  • OTHER Medical Chart Review

Study Locations (10)

Florida

  • University of Florida - Gainesville
  • Moffitt Cancer Center - Tampa

Massachusetts

  • Dana-Farber Harvard Cancer Center - Boston

Minnesota

  • University of Minnesota/Masonic Cancer Center - Minneapolis

New York

  • Roswell Park Cancer Institute - Buffalo

Ohio

  • Cleveland Clinic Foundation - Cleveland

Pennsylvania

  • UPMC Hillman Cancer Center - Pittsburgh

Tennessee

  • Vanderbilt University/Ingram Cancer Center - Nashville

Washington

  • Fred Hutch/University of Washington Cancer Consortium - Seattle

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2020-06-29
Est. Completion 2026-08-02

Sponsor

Fred Hutchinson Cancer Center

483 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04431479

The ClinicalTrials.gov registry entry for NCT04431479 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 106-participant average among 30 other Chronic Graft Versus Host Disease trials with a reported enrollment target (183% higher). The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Graft Versus Host Disease appearing as the primary indexed condition, and to 4 interventions - of which Biospecimen Collection is the first listed.

NCT04431479 reports 10 study locations spanning 9 distinct geographic areas - top geographies include Florida, Massachusetts, Minnesota.

Frequently Asked Questions

What is clinical trial NCT04431479 about?

NCT04431479 is a clinical study titled "Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study". This trial collects clinical data and blood samples to predict the quality of response to specific treatments in patients with chronic graft-versus-host disease (cGVHD) who are about to start a new therapy. Collecting and analyzing clinical data and blood samples from patients with cGVHD before and ...

What is the current status of trial NCT04431479?

This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2020-06-29. Estimated completion is 2026-08-02.

What conditions does trial NCT04431479 study?

This clinical trial studies the following conditions: Chronic Graft Versus Host Disease.

What interventions are being tested in trial NCT04431479?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Medical Chart Review (OTHER).

Who is sponsoring clinical trial NCT04431479?

This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04431479 being conducted?

This trial has 10 study locations across Florida, Massachusetts, Minnesota, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Graft Versus Host Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chronic Graft Versus Host Disease

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.